Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yungu Biomedical Technology, often referred to as CloudValley Biomedical, is a Chinese biotechnology company that specializes in high-throughput DNA synthesis and synthetic biology infrastructure. The company has developed a proprietary silicon-based DNA synthesis chip platform designed to significantly increase throughput while reducing the costs associated with traditional chemical synthesis methods. Their technology supports various applications including gene synthesis, DNA data storage, and the development of oligo pools for drug discovery and diagnostics. Founded in 2021 by industry veterans from prominent genomic organizations, Yungu Biomedical aims to decentralize genetic manufacturing with benchtop synthesis solutions. The company is headquartered in Hangzhou and has secured significant backing from major venture capital firms to expand its manufacturing and R&D capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Yungu Biomedical Technology Co., Ltd..